Great Point Partners’s Exelixis EXEL Stock Holding History

Great Point Partners’s Portfolio EXEL Stock Details EXEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-500,000	Closed	-$10.8M	–	35
2018 Q2	$10.8M	Buy	+500,000	New	+$10.3M	1.49%	24

Other funds holding EXEL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Great Point Partners's EXEL Position: Q2 2022 in Review

Great Point Partners sold out of Exelixis (EXEL) in Q2 2022, closing a stake of 1,300,000 shares — an estimated $29.5M sold.

Great Point Partners first reported a position in EXEL in Q3 2014 and held it in 16 quarters. The position peaked at $36.8M in Q3 2018. 373 funds tracked by Wall St. Rank hold EXEL as of Q2 2022.

Great Point Partners reported no remaining Exelixis position as of Q2 2022 after selling out during the quarter.
Great Point Partners sold 1,300,000 Exelixis shares in Q2 2022, an estimated $29.5M.
Great Point Partners first reported a position in Exelixis in Q3 2014 and held it in 16 quarters.
Great Point Partners's Exelixis position peaked at $36.8M in Q3 2018.
373 funds tracked by Wall St. Rank held Exelixis as of Q2 2022.

Based on Great Point Partners's 13F filing for Q2 2022, filed 15 Aug 2022.